FitLife Brands (NASDAQ:FTLF) & Curaleaf (OTCMKTS:CURLF) Head to Head Comparison

FitLife Brands (NASDAQ:FTLF) and Curaleaf (OTCMKTS:CURLF) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, valuation, dividends and profitability.

Institutional and Insider Ownership

2.3% of FitLife Brands shares are held by institutional investors. Comparatively, 0.0% of Curaleaf shares are held by institutional investors. 61.2% of FitLife Brands shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares FitLife Brands and Curaleaf’s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FitLife Brands	$52.70 million	2.51	$5.30 million	$1.08	26.60
Curaleaf	$1.35 billion	2.39	-$281.20 million	($0.39)	-12.82

FitLife Brands has higher earnings, but lower revenue than Curaleaf. Curaleaf is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares FitLife Brands and Curaleaf’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
FitLife Brands	10.05%	27.17%	14.23%
Curaleaf	-20.77%	-12.93%	-4.65%

Risk and Volatility

FitLife Brands has a beta of 0.85, meaning that its share price is 15% less volatile than the S&P 500. Comparatively, Curaleaf has a beta of 1.77, meaning that its share price is 77% more volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and price targets for FitLife Brands and Curaleaf, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FitLife Brands	0	0	0	0	N/A
Curaleaf	1	1	3	0	2.40

Curaleaf has a consensus target price of $18.75, suggesting a potential upside of 275.00%. Given Curaleaf’s higher possible upside, analysts clearly believe Curaleaf is more favorable than FitLife Brands.

Summary

FitLife Brands beats Curaleaf on 8 of the 12 factors compared between the two stocks.

About FitLife Brands

FitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally. The company provides weight loss, sports nutrition, and general health products; sports nutrition products; weight loss and sports nutrition products; sports nutrition and general wellness formulations with an emphasis on natural, vegan, and organic ingredients; and male health and weight loss products, as well as other diet, health, and sports nutrition supplements and related products; and value-oriented sports nutrition and weight loss products. It offers MRC products which includes general health supplements; and natural skincare and beauty products. In addition, it markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Nutrology, Metis Nutrition, iSatori, BioGenetic Laboratories, Energize, Dr. Tobias, All-Natural Advice, and Maritime Naturals through franchised stores, as well as through retail locations, which include specialty, mass, and online. The company was formerly known as Bond Laboratories, Inc. and changed its name to FitLife Brands, Inc. in September 2013. FitLife Brands, Inc. was incorporated in 2005 and is headquartered in Omaha, Nebraska.

About Curaleaf

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.